Article
Ranbaxy is launching its isotretinoin product for the treatment of acne, Absorica, in the United States.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Survey Snapshot: Chronic Hand Eczema's Clinical Burden, Treatment Gaps, and Patient Impact Revealed
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
AAD Partners With SOCS to Launch Inclusive Image Library
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Building Trust Through Cultural Competency in Aesthetic Dermatology
Exploring the Role of GLP-1 Receptor Agonists in Psoriasis